Outcomes of thoracic endovascular aortic repair using fenestrated stent grafts in patients with thoracic aortic distal arch aneurysms

• Published in: European journal of cardio-thoracic surgery 2024-03, Vol.65 (3)
• Main Authors: Okamoto, Takeshi, Yokoi, Yoshihiko, Sato, Noriaki, Suzuki, Shuhei, Enomoto, Takashi, Onishi, Ryo, Nakamura, Norihito, Okubo, Yuka, Nagasawa, Ayako, Mishima, Takehito, Shiraishi, Shuichi, Tsuchida, Masanori
• Format: Article
• Language: English
• Subjects: Aneurysm, Aortic Arch; Aortic Aneurysm, Thoracic - etiology; Aortic Aneurysm, Thoracic - surgery; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation - adverse effects; Endoleak - etiology; Endovascular Aneurysm Repair; Endovascular Procedures - adverse effects; Humans; Prosthesis Design; Retrospective Studies; Stents; Time Factors; Treatment Outcome
• ISSN: 1873-734X; 1873-734X
• DOI: 10.1093/ejcts/ezae062

Thoracic endovascular aortic repair (TEVAR) for aortic arch aneurysms is challenging because of anatomical restrictions and the presence of cervical branches. Revascularization of the cervical branch is required when conventional commercial stent grafts are used. TEVAR using fenestrated stent grafts (FSG) often does not require additional procedures to revascularize cervical branches. This study aimed to evaluate the features and initial and midterm outcomes of TEVAR using fenestrated stent grafts. From April 2007 to December 2016, 101 consecutive patients underwent TEVAR using fenestrated stent grafts for distal aortic arch aneurysms at a single centre. Technical success, complications, freedom from aneurysm-related death, secondary intervention and aneurysm progression were retrospectively investigated. All the patients underwent TEVAR using fenestrated stent grafts. The 30-day mortality rate was zero. Cerebral infarction, access route problems and spinal cord injury occurred in 4, 3 and 2 patients, respectively. Each type of endoleak was observed in 38 of the 101 patients during the course of the study; 20/38 patients had minor type 1 endoleaks at the time of discharge. The endoleak disappeared in 2 patients and showed no significant change in 8 patients; however, the aneurysm expanded over time in 10 patients. Additional treatment was performed in 8 of the 10 patients with type 1 endoleaks and dilatation of the aneurysm. The rate of freedom from aneurysm-related death during the observation period was 98%. TEVAR with FSG is a simple procedure, with few complications. Additional treatment has been observed to reduce aneurysm-related deaths, even in patients with endoleaks and enlarged aneurysms. Based on this study, the outcomes of endovascular repair of aortic arch aneurysms using a fenestrated stent graft seem acceptable.